Report Summary
Long Acting Insulins (are also called basal or background insulins) can control blood sugar for an entire day. Bovine PZI (protamine zinc insulin), can last anywhere up to 36 hours. Long acting insulins are available in animal and analogue forms. They can be used for a number of different types of diabetes.
In 2020, the global Long Acting Insulins market size was xx million US$ and it is expected to reach xx million US$ by the end of 2027, with a CAGR of xx% during 2021-2027.
This report focuses on the global Long Acting Insulins status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Long Acting Insulins development in United States, Europe and China.
The key players covered in this study
Novo Nordisk
Sanofi
Wockhardt UK
...
Market segment by Type, the product can be split into
Insulin Glargine
Insulin Determir
Insulin Degludec
Long Acting Animal Insulin
Market segment by Application, split into
Home Use
Medical Institutions
Others
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Long Acting Insulins status, future forecast, growth opportunity, key market and key players.
To present the Long Acting Insulins development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Long Acting Insulins are as follows:
History Year: 2017-2020
Base Year: 2020
Estimated Year: 2020
Forecast Year 2021 to 2027
For the data information by region, company, type and application, 2020 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table Of Contents
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Long Acting Insulins Market Size Growth Rate by Type (2017-2027)
1.4.2 Insulin Glargine
1.4.3 Insulin Determir
1.4.4 Insulin Degludec
1.4.5 Long Acting Animal Insulin
1.5 Market by Application
1.5.1 Global Long Acting Insulins Market Share by Application (2017-2027)
1.5.2 Home Use
1.5.3 Medical Institutions
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Long Acting Insulins Market Size
2.2 Long Acting Insulins Growth Trends by Regions
2.2.1 Long Acting Insulins Market Size by Regions (2017-2027)
2.2.2 Long Acting Insulins Market Share by Regions (2017-2020)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Long Acting Insulins Market Size by Manufacturers
3.1.1 Global Long Acting Insulins Revenue by Manufacturers (2017-2020)
3.1.2 Global Long Acting Insulins Revenue Market Share by Manufacturers (2017-2020)
3.1.3 Global Long Acting Insulins Market Concentration Ratio (CR5 and HHI)
3.2 Long Acting Insulins Key Players Head office and Area Served
3.3 Key Players Long Acting Insulins Product/Solution/Service
3.4 Date of Enter into Long Acting Insulins Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Long Acting Insulins Market Size by Type (2017-2020)
4.2 Global Long Acting Insulins Market Size by Application (2017-2020)
5 United States
5.1 United States Long Acting Insulins Market Size (2017-2020)
5.2 Long Acting Insulins Key Players in United States
5.3 United States Long Acting Insulins Market Size by Type
5.4 United States Long Acting Insulins Market Size by Application
6 Europe
6.1 Europe Long Acting Insulins Market Size (2017-2020)
6.2 Long Acting Insulins Key Players in Europe
6.3 Europe Long Acting Insulins Market Size by Type
6.4 Europe Long Acting Insulins Market Size by Application
7 China
7.1 China Long Acting Insulins Market Size (2017-2020)
7.2 Long Acting Insulins Key Players in China
7.3 China Long Acting Insulins Market Size by Type
7.4 China Long Acting Insulins Market Size by Application
8 Japan
8.1 Japan Long Acting Insulins Market Size (2017-2020)
8.2 Long Acting Insulins Key Players in Japan
8.3 Japan Long Acting Insulins Market Size by Type
8.4 Japan Long Acting Insulins Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Long Acting Insulins Market Size (2017-2020)
9.2 Long Acting Insulins Key Players in Southeast Asia
9.3 Southeast Asia Long Acting Insulins Market Size by Type
9.4 Southeast Asia Long Acting Insulins Market Size by Application
10 India
10.1 India Long Acting Insulins Market Size (2017-2020)
10.2 Long Acting Insulins Key Players in India
10.3 India Long Acting Insulins Market Size by Type
10.4 India Long Acting Insulins Market Size by Application
11 Central & South America
11.1 Central & South America Long Acting Insulins Market Size (2017-2020)
11.2 Long Acting Insulins Key Players in Central & South America
11.3 Central & South America Long Acting Insulins Market Size by Type
11.4 Central & South America Long Acting Insulins Market Size by Application
12 International Players Profiles
12.1 Novo Nordisk
12.1.1 Novo Nordisk Company Details
12.1.2 Company Description and Business Overview
12.1.3 Long Acting Insulins Introduction
12.1.4 Novo Nordisk Revenue in Long Acting Insulins Business (2017-2020)
12.1.5 Novo Nordisk Recent Development
12.2 Sanofi
12.2.1 Sanofi Company Details
12.2.2 Company Description and Business Overview
12.2.3 Long Acting Insulins Introduction
12.2.4 Sanofi Revenue in Long Acting Insulins Business (2017-2020)
12.2.5 Sanofi Recent Development
12.3 Wockhardt UK
12.3.1 Wockhardt UK Company Details
12.3.2 Company Description and Business Overview
12.3.3 Long Acting Insulins Introduction
12.3.4 Wockhardt UK Revenue in Long Acting Insulins Business (2017-2020)
12.3.5 Wockhardt UK Recent Development
13 Market Forecast 2021-2027
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2021-2027)
13.10 Market Size Forecast by Application (2021-2027)
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
